Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant: Secondary Data Analysis for Cancer Prevention and Control

University of Alberta

$75,000.00

Epidemiology of Rare Cancers in Canada: Developing a framework for surveillance, cost analysis and etiologic research.

EF 2017-18

Résumé
Rare cancers make up approximately 25-35% of new cancer cases in Canada annually. However, research on this group of cancers receives little scientific attention and fiscal support, relative to common cancers. Because of this, the magnitude of the societal burden attributable to rare cancers is poorly defined, limiting progress in improving patient outcomes. This project will identify strategies for improving the efficiency of surveillance and etiologic research on rare cancers. We will create the first pan-Canadian surveillance report focused on rare cancers, including estimates of the cumulative cost of diagnosis and treatment for these cancers. A preliminary analysis of data from the Canadian Partnership for Tomorrow Project will assess the feasibility of using this multi-province cohort for research assessing risk factors for rare cancers.
Programme
Operating Grant: Secondary Data Analysis for Cancer Prevention and Control
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
377861
Name
Davis Faith G
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Secondary Data Analysis - All Other Cancers
Projecttitle
Epidemiology of Rare Cancers in Canada: Developing a framework for surveillance, cost analysis and etiologic research.
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$75,000
Cihrequipment2
$0
Programname2
Operating Grant: Secondary Data Analysis for Cancer Prevention and Control
Keyworddelim
Cancer Surveillance; Cost Analysis; Epidemiology Methods; Etiologic Research; Rare Cancers
Abstract
Rare cancers make up approximately 25-35% of new cancer cases in Canada annually. However, research on this group of cancers receives little scientific attention and fiscal support, relative to common cancers. Because of this, the magnitude of the societal burden attributable to rare cancers is poorly defined, limiting progress in improving patient outcomes. This project will identify strategies for improving the efficiency of surveillance and etiologic research on rare cancers. We will create the first pan-Canadian surveillance report focused on rare cancers, including estimates of the cumulative cost of diagnosis and treatment for these cancers. A preliminary analysis of data from the Canadian Partnership for Tomorrow Project will assess the feasibility of using this multi-province cohort for research assessing risk factors for rare cancers.
Competitiondate
201711
Approvedterm2
1 yr 0 mth
Pinamesdelim
Davis, Faith G
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $75,000~ $0~